Gunther Birznieks

Insider Reports History

Location
Washington, DC
Signature
/s/ Gunther Birznieks
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gunther Birznieks:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. SVP, Business Development Common Stock 494,197 $4,084,982 $8.27 02 Mar 2026 Direct

Insider Reports Filed by Gunther Birznieks

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VNDA Vanda Pharmaceuticals Inc. 02 Mar 2026 1 -$350,730 4 SVP, Business Development 04 Mar 2026, 18:51
VNDA Vanda Pharmaceuticals Inc. 18 Feb 2026 1 $0 4 SVP, Business Development 19 Feb 2026, 17:51
VNDA Vanda Pharmaceuticals Inc. 01 Mar 2025 1 -$128,239 4 SVP, Business Development 04 Mar 2025, 16:46
VNDA Vanda Pharmaceuticals Inc. 18 Feb 2025 1 $0 4 SVP, Business Development 20 Feb 2025, 19:44
VNDA Vanda Pharmaceuticals Inc. 04 Mar 2024 2 -$73,379 4 SVP, Business Development 06 Mar 2024, 16:46
VNDA Vanda Pharmaceuticals Inc. 16 Feb 2024 1 $0 4 SVP, Business Development 21 Feb 2024, 16:50
VNDA Vanda Pharmaceuticals Inc. 02 Mar 2023 2 -$104,584 4 SVP, Business Development 06 Mar 2023, 17:24
VNDA Vanda Pharmaceuticals Inc. 16 Feb 2023 2 $0 4 SVP, Business Development 21 Feb 2023, 17:08
VNDA Vanda Pharmaceuticals Inc. 26 Aug 2022 2 +$3,900 4 SVP, Business Development 29 Aug 2022, 17:02
VNDA Vanda Pharmaceuticals Inc. 28 Feb 2022 4 -$175,492 4 SVP, Business Development 02 Mar 2022, 20:26